summary

UCLA Health - BRAF Mutation in Thyroid Cancer | UCLA Endocrine Center

Thumbnail of the video “UCLA Health - BRAF Mutation in Thyroid Cancer | UCLA Endocrine Center”
Community upload. AI output has not been independently verified.

Short Summary

Main recommendation: If a pathology report shows a BRAF V600E mutation in thyroid cancer, do not panic, because the mutation alone is usually not a major concern and most patients live normal, healthy lives. Dr. Michael Yay of UCLA Health Endocrine Surgery explains that BRAF V600E is a somatic (acquired) mutation that drives cells to grow too fast and spread, but its effect on outcome depends on context such as age, sex, and co-occurring mutations.

Key Points

  • BRAF V600E is a somatic mutation, present only in cancer cells, so it is not inherited and cannot be passed on to children.
  • It appears in about 40% of all thyroid cancers and about 50% of papillary thyroid cancers, the most common type (more than 90% of new diagnoses in the United States).
  • About 10 years ago it was thought to predict higher recurrence or mortality, but newer understanding shows that about 95% of patients with papillary thyroid cancer do very well.
  • Risk is context-dependent: patients aged 55 and up and men with the mutation may have a slightly higher chance of aggressive disease.
  • Combined with other mutations such as TERT or TP53 (called "double hits" or "late hit" mutations, found in about 5% of thyroid cancers), the combination can signal a more aggressive cancer.
  • Targeted therapies that block the BRAF mutation are available for the small number of patients whose cancer behaves aggressively.

Details Worth Noting

  • Concrete instructions: If your biopsy or surgical pathology report shows BRAF V600E, do not panic, and talk to a thyroid cancer specialist about your questions and your individual risk.
  • The speaker contrasts somatic mutations (acquired during life, as in this case) with germline mutations (present in every cell and inherited from parents).
  • BRAF is a gene that normally helps control cell growth; the V600E change makes cells grow too much and too fast and can help cancer cells spread into nearby tissue.
  • The mutation also occurs in skin cancer, melanoma, colorectal cancer, and lung cancers.
  • The speaker notes that the mutation alone is not the full story for outcomes; other genes and factors also play a role.

Bottom Line

The BRAF V600E mutation is a factor to understand with your care team rather than a reason for alarm, since its meaning depends on your age, sex, and any additional mutations found alongside it.

Facts

  1. The BRAF V600E mutation is found in about 40% of all thyroid cancers and about 50% of papillary thyroid cancers.

    4:00